Why Savvy Investors Are Eyeing Merck Despite Market Volatility
Merck & Co., Inc. (NYSE:MRK) stands out as a resilient investment amid volatile market conditions. Despite economic uncertainties, the U.S. economy shows strength with a 3% GDP growth and 4% unemployment rate. Merck’s groundbreaking drugs, particularly KEYTRUDA, boost earnings, with a 21% sales increase in Q4 2024. Merck’s forward P/E ratio of 10.34 suggests it … Read more